SAN FRANCISCO — A plaintiff who developed a severe reaction to the drug Motrin can pursue a punitive damages claim against Johnson & Johnson and one of its subsidiaries after the California Supreme Court on Wednesday declined to review the case.

The court also decided against depublishing the court of appeal decision denying Johnson & Johnson’s petition for a writ of mandate in the failure-to-warn case.